###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
In order to understand the spectrum and frequency of GJB2 mutations in the Chinese population, the coding region of the GJB2 gene from 2063 unrelated patients with NSHI was PCR amplified and sequenced.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 421 429 <span type="species:ncbi:9606">patients</span>
A total of 23 pathogenic mutations were identified. Among them, five (p.W3X, c.99delT, c.155_c.158delTCTG, c.512_c.513insAACG, and p.Y152X) are novel. Three hundred and seven patients carry two confirmed pathogenic mutations, including 178 homozygotes and 129 compound heterozygotes. One hundred twenty five patients carry only one mutant allele. Thus, GJB2 mutations account for 17.9% of the mutant alleles in 2063 NSHI patients. Overall, 92.6% (684/739) of the pathogenic mutations are frame-shift truncation or nonsense mutations. The four prevalent mutations; c.235delC, c.299_c.300delAT, c.176_c.191del16, and c.35delG, account for 88.0% of all mutantalleles identified. The frequency of GJB2 mutations (alleles) varies from 4% to 30.4% among different regions of China. It also varies among different sub-ethnic groups.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
In some regions of China, testing of the three most common mutations can identify at least one GJB2 mutant allele in all patients. In other regions such as Tibet, the three most common mutations account for only 16% the GJB2 mutant alleles. Thus, in this region, sequencing of GJB2 would be recommended. In addition, the etiology of more than 80% of the mutant alleles for NSHI in China remains to be identified. Analysis of other NSHI related genes will be necessary.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 63 69 <span type="species:ncbi:9606">humans</span>
###xml 128 136 <span type="species:ncbi:9606">children</span>
Hearing impairment is the most common neurosensory disorder in humans. The reported incidence varies from 1 in 300 to 1 in 1000 children [1-4]. Approximately half of cases have a genetic etiology, including syndromic and non-syndromic forms, with extraordinary genetic heterogeneity. Non-syndromic deafness accounts for 60-70% of inherited hearing impairment. It involves more than 100 different genes with autosomal dominant (DFNA), autosomal recessive (DFNB), X-linked (DFN), and maternal inheritance [5], with autosomal recessive being the most common. For many populations, the most common cause for non-syndromic autosomal recessive hearing loss is mutated Connexin 26, a gap junction protein encoded by the GJB2 gene (MIM 121011) [6-13]. There are a few specific mutations in GJB2 gene that are associated with the autosomal dominant syndromic forms of deafness, and typically present with skin abnormalities including keratitis-ichthyosis [14-16].
###end p 11
###begin p 12
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Connexins are transmembrane proteins. Six monomers of connexin proteins associate to form a transmembrane hexameric gap junction hemi-channel called a connexon. Connexons embedded in the surfaces of adjacent cells associate to form an intercellular channel [17,18]. In the inner ear, connexin 26 can be in association with other connexins to form heteromeric connexons. Gap junction channels can be homotypic or heterotypic. Connexin 26 gap junction channels recycle potassium ions as part of a mechanism of auditory signal transduction in inner ear [19].
###end p 12
###begin p 13
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 429 434 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 579 585 579 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans </italic>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
Mutations in three connexin (Cx) genes, GJB2 (Cx26), GJB6 (Cx30), and GJB3 (Cx31), have been identified and are known to cause hearing impairment [18,19]. Sequence analysis of the GJB2 gene in subjects with autosomal recessive hearing impairment revealed that a high number of patients carried only one mutant allele. Some of these families showed clear evidence of linkage to the DFNB1 locus, which contains two genes, GJB2 and GJB6 [6,20]. Further analysis demonstrated that some GJB2 heterozygotes also carried a truncating deletion of the GJB6 gene, encoding connexin 30, in trans [21,22].
###end p 13
###begin p 14
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
To date, more than 150 mutations, polymorphisms, and unclassified variants have been described in the GJB2 gene . The mutation spectrum and prevalence of mutations vary significantly among different ethnic groups. Three mutations, c.35delG, c.167delT, and c.235delC, are found to be the most frequent mutations in Caucasian, Ashkenazi Jewish, and Asian populations, respectively [6,7,9-13,20,23-26].
###end p 14
###begin p 15
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 851 856 851 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 954 959 954 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1046 1051 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1258 1263 1258 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1456 1461 1456 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1565 1570 1565 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1645 1650 1645 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1711 1716 1711 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1791 1792 1791 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
###xml 1100 1108 <span type="species:ncbi:9606">patients</span>
###xml 1139 1147 <span type="species:ncbi:9606">patients</span>
###xml 1271 1279 <span type="species:ncbi:9606">patients</span>
###xml 1390 1398 <span type="species:ncbi:9606">patients</span>
###xml 1592 1600 <span type="species:ncbi:9606">patients</span>
###xml 1729 1737 <span type="species:ncbi:9606">patients</span>
In China, it is estimated that 30,000 babies are born with congenital hearing impairment every year [27]. The mutation spectrum of the GJB2 gene in Chinese patients with nonsyndromic hearing impairment (NSHI) has not been analyzed. Our recent study by screening for just the most common mutation, c.235delC, in 3004 Chinese NSHI patients revealed that 488 (16.3%) patients carried at least one c.235delC mutant allele, with 233 (7.8%) homozygotes and 255 (8.5%) heterozygotes [28], though the frequencies of homozygote and heterozygote of c.235delC varied from 0% to 14.7% and from 1.7% to 16.1% respectively in the populations examined in this study. Among different Chinese sub-ethnic groups the c.235delC allele frequency was the lowest (0.8%) in the Tibetan and the highest (31.0%) in Maan. These results highlight the need to sequence the entire GJB2 gene in order to more accurately establish the actual mutation frequency and mutation spectrum of GJB2 gene within various Chinese sub-populations. Our preliminary results reveal that other GJB2 mutations account for an additional 7.1% of NSHI patients from Qinghai, where only 7.1% patients carried at least one c.235delC mutation. Nevertheless, sequencing analysis of the entire coding region of the GJB2 gene in patients from Guangxi where the frequency of the c.235delC mutation is 3.4% reveals only one other mutation in 87 deaf patients. These results have two important implications: that the GJB2 gene needs to be sequenced in its entirety; and that mutations in genes responsible for NSHI other than GJB2 should be searched in patients who do not harbor two mutant alleles in the GJB2 gene. In this study, we report the results of sequencing the GJB2 gene in 2063 patients with NSHI from 23 different regions of China (Figure 1).
###end p 15
###begin p 16
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Geographic distribution and the proportion of patients carrying at least one <italic>GJB2 </italic>mutant allele in each region studied</bold>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Geographic distribution and the proportion of patients carrying at least one GJB2 mutant allele in each region studied.
###end p 16
###begin title 17
Materials and methods
###end title 17
###begin title 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and DNA samples
###end title 18
###begin p 19
###xml 193 201 <span type="species:ncbi:9606">patients</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
A total of 2063 unrelated NSHI students from 23 different regions of China were included in this sequencing study. The selection of samples was random regardless of the c.235delC genotype. The patients consisted of 1179 males and 884 females ranging in age from 2 to 30 years with an average age of 13.7 +/- 4.5. The majority of patients were Han Chinese (1640), followed by Tibetan (122), minorities in the Southwest region (119), Hui (79), minorities in Xinjiang (62), Mongolian (21), Maan (18) and Korean (2). Ethnic subgroup designations were based on permanent residency documentation.
###end p 19
###begin p 20
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
This study was performed according to a protocol approved by the ethics committee of the Chinese PLA General Hospital. The subjects in this study were from deaf schools of each region and were recently described [28]. Only the unrelated patients with nonsyndromic hearing loss were included in this study. Parents were not included in this study. All patients showed moderate to profound bilateral sensorineural hearing impairment on audiograms and no pathient with mild hearing impairment was found in this cohort. In addition to the 2063 patients, 301 Han control individuals with normal hearing (either evaluated by pure tone audiometry or by self-assessment) from Beijing Capital (Northern) and Jiangsu Province (Eastern), two densely populated regions consisting of 98% Han Chinese, were also analyzed. DNA was extracted from peripheral blood leukocytes using a commercially available DNA extraction kit (Watson Biotechnologies Inc, Shanghai, China).
###end p 20
###begin title 21
Sequence analysis
###end title 21
###begin p 22
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1060 1065 1060 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1119 1124 1119 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1349 1352 1349 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB</italic>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 1253 1261 <span type="species:ncbi:9606">Children</span>
The coding exon (Exon2) and flanking intronic regions of GJB2 gene were PCR amplified with forward primer 5'TTGGTGTTTGCTCAGGAAGA 3' and reverse primer 5'GGCCTACAGGGGTTTCAAAT 3'. Among this study cohort, 851 patients from central China were also analyzed for mutations in Exon1 and flanking introns by PCR/sequencing. The PCR primers used are forward primer: 5'CTCATGGGGGCTCAAAGGAACTAGGAGATCGG3' and reverse primer 5'GGGGCTGGACCAACACACGTCCTTGGG3'. The PCR products were purified on Qia-quick spin columns (Qiagen, Valencia, CA) and sequenced using the BigDye Terminator Cycle Sequencing kit (version v3.1) and ABI 3130 automated DNA sequencers (Applied Biosystems, Foster City, CA, USA,) with Sequence Analysis Software (Sequencing Analysis version 3.7). DNA sequence variations were identified by comparison of subject DNA sequence to GJB2 reference sequences, Genebank Accession Number . Numbering of GJB2 begins with the nucleotide A of the ATG start codon in Exon2 as cDNA position number 1. The sequences were analyzed using Genetool Lite software and the GJB2 Genebank sequence. The presence of 309 kb deletion of GJB6 was analyzed by PCR method [21,22]. A positive control of this deletion provided by Balin Wu (Department of Laboratory Medicine, Children's Hospital and Harvard Medical School, USA.) was used for the detection of deletion in GJB6 gene.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
The statistical analysis was performed using SAS 9.1.3 software (SAS, Cary, North Carolina, USA).
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
Mutations in GJB2 gene
###end title 26
###begin p 27
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1108 1109 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1412 1413 1412 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1501 1502 1501 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1525 1526 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1594 1599 1594 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1655 1656 1655 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1703 1708 1703 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1785 1786 1785 1786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1963 1968 1963 1968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 2594 2599 2594 2599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 775 783 <span type="species:ncbi:9606">patients</span>
###xml 916 924 <span type="species:ncbi:9606">patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
###xml 1047 1055 <span type="species:ncbi:9606">patients</span>
###xml 1721 1729 <span type="species:ncbi:9606">patients</span>
###xml 2326 2334 <span type="species:ncbi:9606">Patients</span>
Sequencing of the coding region of the GJB2 gene revealed that at least 104 different genotypes were found in the 2063 patients (Table 1). Among them, 64 different genotypes harboring pathogenic mutations were found in 432 patients (Table 1). Three hundred and seven patients had two confirmed pathogenic mutations, including 178 homozygotes and 129 compound heterozygotes. One hundred twenty five patients carried one heterozygous pathogenic mutation without an identified second mutant allele. Thus, GJB2 mutant alleles account for 17.9% (739/4126) of the total alleles in 2063 NSHI patients. The most common genotype was homozygous c.235delC, followed by compound heterozygosity for c.235delC/c.299_300delAT, which accounted for 8.0% (164/2063) and 3.2% (66/2063) of NSHI patients respectively. The most common mutation c.235delC was in compound heterozygosity with 14 other different pathogenic mutations in 113 patients, and was present as a single heterozygous mutant allele in 68 patients. In addition, there were 23 different genotypes in patients carrying one allele of unclassified variants (Table 1). Twenty-three alterations were found, five (p.W3X, c.99delT, c.155_c.158delTCTG, p.Y152X, and c.512_c.513insAACG) of them were novel and pathogenic, and twelve (p,G21R, p,I30F, p.F31L, p.V37I, p.V63L, p.T123N, p.V153A, p.D159N, p.F191L, p.M195V, p.V198M, and p.I215N) are unclassified variants (Table 1 and Supplemental Table 1). The distribution of various genotypes in 23 regions (Figure 1) is detailed in Table 2 and Supplemental Table 2. The frequencies of the three most common GJB2 mutations in the 23 regions studied are listed in Table 2. The allele frequency of all mutations in the GJB2 gene in NSHI patients varied from 4.0% in Guangxi to 30.4% in Jiangsu (Table 2). Regions which appeared to have a higher frequency of the c.235delC mutation (Jiangsu, Inner Mongolia, Beijing, Hebei, Shanghai) also had a relatively high frequency of other GJB2 mutations (eg, the frequency of the c.235delC mutation in Jiangsu was as high as 20.6% and the frequencies of other mutations were also as high as 9.8%). Similarly, regions such as Shaanxi and Guangxi where the frequency of the c.235delC mutation is low (5.8 and 3.4% respectively), also had lower frequencies of other mutations (1.9 and 0.6% respectively). Patients from Tibet, Yunnan, Xinjiang, Heilongjiang, and Ningxia appear to have the most diverse mutation spectrum because uncommon mutations (except c.235delC, c.299_c.300delAT and c.176_c.191del16) comprise 84.2, 30.8, 26.1, 21.4, and 20.4%, respectively of overall GJB2 mutations in those regions.
###end p 27
###begin p 28
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
GJB2 genotypes of 2063 Chinese NSHI patients
###end p 28
###begin p 29
nv: no variant
###end p 29
###begin p 30
Note: p.V37I is controversy variant, see the discussion.
###end p 30
###begin p 31
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
Prevalence of GJB2 mutations in different areas of China
###end p 31
###begin p 32
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
homo: homozygous; het: hetrozygous; apercentage of total mutant alleles identified.
###end p 32
###begin title 33
Frame-shift and nonsense Pathogenic Mutations
###end title 33
###begin p 34
###xml 1049 1054 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1581 1586 1581 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 705 713 <span type="species:ncbi:9606">patients</span>
###xml 896 904 <span type="species:ncbi:9606">patients</span>
###xml 1204 1212 <span type="species:ncbi:9606">patients</span>
###xml 1224 1232 <span type="species:ncbi:9606">patients</span>
###xml 1255 1263 <span type="species:ncbi:9606">patients</span>
###xml 1338 1346 <span type="species:ncbi:9606">patients</span>
###xml 1361 1367 <span type="species:ncbi:9606">people</span>
The c.235delC is the most prevalent mutation in the Chinese NSHI population with a total of 509 alleles (164 homozygous, 113 compound heterozygous with other pathogenic mutant alleles, and 68 one heterozygous allele only), followed by 98 c.299_c.300delAT mutant alleles (8 homozygotes, 76 compound heterozygotes, and 6 one allele heterozygotes), 31 c.176_c.191del16 mutant alleles (2 homozygous, 25 compound heterozygous and 2 with only one allele), and 12 c.35delG mutant alleles(2 homozygous, 3 compound heterozygous and 2 with only one allele) (Supplemental Table 1). The four prevalent mutations account for 88.0% (650/739) of all mutant alleles identified. Five novel mutations were identified in 20 patients; including two nonsense; p.W3X, p.Y152X, and 4 frame-shift truncation mutations; c.99delT, c.155-c.158 delTCTG, and c.512-c.513 insAACG. Among these, c.512-c.513insAACG occurs in 12 patients, including one homozygous from Yunnan. The novel truncation mutations account for only about 3.1% (23/739, Supplemental Table 1) of the overall GJB2 mutant alleles. The most prevalent Caucasian mutation, c.35delG, was found in 2 homozygous, 3 compound heterozygous, and 5 single allele heterozygous patients. Among the patients with c.35delG, 70% of patients (7/10) are Uigur from Xinjiang area. The c.35insG mutation was found in 2 patients (both are Hui people) compound heterozygous with the c.235delC mutation. Other reported frame-shift mutations; 1 c.388-c.397del10 and 3 c.605-c.606ins46, as well as nonsense mutations; 3 p.E47X, account for a small fraction (1.0%) of GJB2 mutant alleles. Overall, 92.6% (684/739) of the pathogenic mutations are frame-shift truncation or nonsense mutations, and they are predicted to cause loss of function of connexin 26. Only 6.9% (51/739) of the mutant alleles are reported missense mutations.
###end p 34
###begin title 35
Reported missense pathogenic mutations
###end title 35
###begin p 36
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
###xml 266 273 <span type="species:ncbi:9606">patient</span>
There are 8 reported missense pathogenic mutations and 1 in-frame deletion of 1 single amino acid, c.424_c.426del3 (p.del142F), which occurs in 4 heterozygous patients (Supplemental Table 1). The 8 missense mutations are p.G4D (3 heterozygous patients), p.R32C (one patient in compound heterozygosity with c.235delC), p.R143W (4 compound heterozygotes), p.T86R (all compound heterozygous, 6 with c.235delC and 1 with c.299_c.300delAT), p.R127H (one compound with p.Y152X, 31 single heterozygotes), p.S139N (2 single heterozygotes), p.E47K (one compound with c.299_c.300delAT), p.S85P (single heterozygote). All occur in an evolutionarily highly conserved region (Figure 2) [26,29,30].
###end p 36
###begin p 37
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amino acid alignment of Connexin26 in different species</bold>
Amino acid alignment of Connexin26 in different species.
###end p 37
###begin title 38
Unclassified Variants
###end title 38
###begin p 39
Twelve unclassified missense variants were identified. The p.G21R is most likely to be pathogenic based on its highly evolutionarily conserved nature and the dramatic effect of the amino acid substitutions on structure and ionic strength. The p.I215N variant is located in the conserved region of C-terminal ion channel domain. Replacing the hydrophobic amino acid isoleucine with a hydrophilic amino acid asparagine in this conserved region is expected to cause detrimental effect. This variant is also in compound heterozygous with a novel pathogenic mutation, c.155_c.158delTCTG. Thus, it is likely to be pathogenic.
###end p 39
###begin p 40
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 541 549 <span type="species:ncbi:9606">patients</span>
###xml 642 649 <span type="species:ncbi:9606">patient</span>
The missense variants, p.I30F, p.F31L, p.V63L, p.V153A, p.D159N, p.F191L, p.M195V, and p.V198M, do not involve drastic change in amino acid structure and polarity. They are all present as single heterozygous alleles without the presence of a second pathogenic mutant allele. Thus, their pathogenicity cannot be determined. Other changes of the same amino acids have been reported. For example, p.V63A has been reported as a novel variant, p.V153I and p.D159N were reported as a polymorphism [29]. The p.M195V and p.V198M, each occurs in two patients, without the second mutant allele. Each of the other variants occurs as heterozygous in one patient. None of these missense variants were detected in the control population.
###end p 40
###begin title 41
Uncharacterized Novel Silent Variants
###end title 41
###begin p 42
Several nucleotide substitutions do not result in amino acid change. These are p.A49A, p. K61K, p.F146F, and p.T186T (p.T186T is heterozygous with a single c.235delC). Although these nucleotide changes do not alter the encoded amino acids, we cannot exclude the possibility that they may activate an exonic splice enhancer and cause aberrant splicing. Alternatively, changes in triplet codon may affect the preference of codon usage or the stability of the mRNA, which in turn can affect the protein levels.
###end p 42
###begin title 43
Genotypes and Carrier Frequency in the Normal Control Population
###end title 43
###begin p 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 530 535 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
GJB2 is a small gene but harbors many mutations. Thus, the carrier frequency of GJB2 mutation in the Chinese population is not negligible. We sequenced the coding region of 301 normal control individuals of the Han ethnic group. Nine individuals were found to be heterozygous carriers of GJB2 pathogenic mutations; three had the c.235delC, three had the c.299_c.300delAT, and the c.512_c.513insAACG, c.35delG, and p.E47X mutation have been detected in single individuals (see Supplemental Table 3). Thus, the carrier frequency of GJB2 mutations in the control population is 3%.
###end p 44
###begin title 45
###xml 36 43 <span type="species:ncbi:9606">patient</span>
Frequencies of missense variants in patient and control populations
###end title 45
###begin p 46
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 348 355 <span type="species:ncbi:9606">patient</span>
###xml 644 651 <span type="species:ncbi:9606">patient</span>
The frequencies of common missense variants such as p.V37I, p.V27I, p.I203T, p.T123N, p.E114G in patients, control, and other Asian populations were compared (see Supplemental Table 4 and Table 5). The pathogenic role of p.V37I has been controversial [24-26,30-33]. It was found that the p.V37I allele frequency was significantly higher in the Han patient group (excluding all cases with two clearly pathogenic mutations) than in the control group (6.7% and 2.8% respectively,. p = 0.0003), supporting a pathogenic role of p.V37I. The allele frequencies of p.V27I, p.E114G, p.I203T, and p.T123N were higher in the control group than in the Han patient group (excluding all cases with two clearly pathogenic mutations), arguing against their pathogenic role (see Supplemental Table 4 and Table 5).
###end p 46
###begin title 47
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
GJB2 mutation spectra among different sub-ethnic groups in China
###end title 47
###begin p 48
###xml 22 23 22 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1244 1249 1244 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1551 1556 1551 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1770 1775 1770 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 307 310 <span type="species:ncbi:9606">Man</span>
###xml 991 998 <span type="species:ncbi:9606">patient</span>
###xml 1106 1114 <span type="species:ncbi:9606">patients</span>
As indicated in Table 2, the frequency of GJB2 mutations varies from 4% in Guangxi to 30.4% in Jiangsu. These results suggest that the variation in mutation frequencies may be due to ethnic diversity in various regions. The total population of China is 1.3 billion and sub-populations of Han, Tibetan, Hui, Man, Mon, minorities in Xinjiang, and minorities in South-western China are 1137.4 million, 5.4 million, 9.8 million, 10.7 million, 5.8 million, 10.8 million, and 57.1 million, respectively (, ). We therefore analyzed the mutation frequencies in different sub-ethnic groups. As shown in Supplemental Table 6, Hui has the highest frequency of overall GJB2 mutations, followed by Han and minorities in Xinjiang with 20.3, 19.1, and 15.3% respectively. Tibetan and the minorities in the Southwest have lower mutation frequencies, 9.4 and 5.0% respectively, similar to the frequencies observed in corresponding regions. The majority of mutations found in this study were found in the Han patient group (1640 cases) only except c.35 insG that was in compound heterozygous with c.235delC found in two Hui patients. The common Caucasian mutation, c.35delG was mainly detected in the minorities of Xinjiang, and accounted for almost half of the GJB2 mutant alleles in minorities of Xinjiang (9 c.35delG/19 total mutant alleles). The finding of the c.35delG mutation in Xinjiang may be due in part to the close vicinity of Xinjiang to Russia and Eastern European countries, and possible admixture. The Maan sub-ethnic group also appears to have diverse GJB2 mutation spectrum because mutations other than c.235delC account for more than one third of the mutant alleles. The three most common mutations c.235delC, c.299_c.300delAT, and c.176_c.191del16 account for 100% of GJB2 mutations in 18 Mongolian individuals analyzed. However, the sample size is too small to be statistically significant.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 842 847 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1434 1439 1434 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1537 1542 1537 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1663 1668 1663 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1690 1695 1690 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
###xml 817 825 <span type="species:ncbi:9606">patients</span>
###xml 1378 1386 <span type="species:ncbi:9606">patients</span>
###xml 1799 1807 <span type="species:ncbi:9606">patients</span>
Previous reports have suggested that the prevalence of GJB2 mutations among different ethnic groups varies. In our patients, the most common Caucasian mutation, c.35delG was only found in 10 patients (seven of them were Uigur from Xinjiang). Instead, the c.235delC account for 68.9% of all GJB2 mutant alleles in our Chinese study population. These results support that the c.235delC mutation in connexin 26 gene is the most prevalent mutation in most Asian populations, including Han Chinese [11,24,30,34]. The results from this study indicate that analysis of four common mutations, c.235delC, c.299_c.300delAT, c.176_c.191del16, and 35delG can detect 88.0% (650/739) of GJB2 mutations. In 13 regions of China, by analyzing these four mutations, we were able to identified at least one mutant allele in all studied patients with one or two GJB2 mutations (see Table 2 and Supplemental Table 2). In contrast, mutations in the GJB2 gene account for a variable proportion of the molecular etiology of NSHI in different regions and sub-ethnic groups in China. Our results have tremendous impact on the design of molecular diagnostic and carrier testing of NSHI families in China. For example, in addition to the three most common mutations of c.235delC, c.299_c.300delAT, c.176_c.191del16, for minorities in Xinjiang, testing of Caucasian c.35delG mutation should be included. In patients with Maan ethnic background, sequencing of the GJB2 coding region should be offered, since the analysis of three common mutations detects only 71% of GJB2 mutant alleles. In minorities from Southwest provinces, although the three most common mutations account for >90% of all GJB2 mutations, defects in GJB2 gene account for only a small fraction (5%, Supplemental Table 2 and Table 6) of mutant alleles in NSHI patients. Thus, in these groups, analysis of other NSHI related genes should be pursued.
###end p 50
###begin p 51
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 825 830 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1073 1078 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1177 1182 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1323 1328 1323 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1393 1398 1393 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1547 1552 1547 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1712 1717 1712 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 1730 1735 1730 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 1758 1760 1758 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1761 1763 1761 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1764 1766 1764 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1858 1863 1858 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1867 1872 1867 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 1873 1874 1873 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1875 1877 1875 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1934 1939 1934 1939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 1956 1961 1956 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 2053 2055 2053 2055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2086 2091 2086 2091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 2168 2173 2168 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 2216 2221 2216 2221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 2282 2287 2282 2287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 2350 2354 2350 2354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6</italic>
###xml 2385 2387 2385 2387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
###xml 802 810 <span type="species:ncbi:9606">patients</span>
###xml 2103 2111 <span type="species:ncbi:9606">patients</span>
###xml 2260 2268 <span type="species:ncbi:9606">patients</span>
We recently reported that 7.8% of patients with autosomal recessive nonsyndromic hearing impairment in China were homozygous for the most common c.235delC mutation in GJB2 gene and 8.5% of them carried one mutant allele of the c.235delC mutation [28]. Sequencing of the coding region of the GJB2 gene reveals that 14.9% of the patients carry two pathogenic GJB2 mutation and 6.1% carry only one mutant allele. These results are comparable to other reported studies [7,11,13,24,29,30,33-35]. The proportions of patients with GJB2 mutations carrying only one mutant allele vary among different regions, different sub-ethnic groups, and different countries [7,11,13,24,29,30,33-35]. The observation that sequence analysis of GJB2 gene in subjects with autosomal recessive NSHI results in a high number of patients with only one GJB2 mutant allele has been puzzling [23]. Our unpublished data showed that no mutation were found in GJB2 Exon1 and its splicing sequence among 851 deaf individuals from Central China in this cohort which suggested extremely low detection rate of GJB2 Exon1 mutation among Chinese deaf population. For there is higher frequency of single heterozygous GJB2 mutation detected in the deaf population than in the normal population in this study, the further more extensive study of sequence change in GJB2 Exon1 or promoter area and 3'-UTR, fragment deletion neighboring GJB2 ORF region and digenic inheritance with other genes are already considered in this large Chinese deaf cohort for elucidating complex pathogenesis of GJB2 gene to hearing impairment. We already added a paragraph in discussion. Thus, a digenic hypothesis was proposed and mutations in two other connexin (Cx) genes, GJB6 for Cx30 and GJB3 for Cx31 were studied [21,22,36]. In families with clear evidence of linkage to the DFNB1 locus, which contains two genes, GJB2 and GJB6 [6,20], a common 309 kb deletion, involving the coding region GJB6 gene upstream of GJB2 gene has been identified and found to account for up to 10% of DFNB1 alleles in Caucasians [22]. We analyzed the deletion in GJB6 gene in 372 patients from Inner Mongolia and central China, and deletions in GJB6 gene were not detected. Similar studies of GJB6 mutations in Taiwanese prelingual NSHI patients carrying one GJB2 mutant allele also did not detect any deleterious mutations in GJB6, consistent with our results [30].
###end p 51
###begin p 52
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
Although the spectrum of rare GJB2 mutations varies among sub-ethnic groups and in different regions of China, the same most common c.235delC mutation is shared. This observation is in agreement with the reports from the studies of other Asian NSHI patients [10,11,24,30,34]. However, instead of c.299_c.300delAT being the second most prevalent mutation, p.G45E accounts for 16% of the Japanese GJB2 mutations, while p.G4D accounts for 10.6% of Taiwanese GJB2 mutant alleles [10,30]. The p.G45E mutation was not detected in our patients. The p.G4D mutation accounts for only 0.3% of GJB2 mutant alleles in Chinese NSHI patients and was recently reported in a US study [29,30].
###end p 52
###begin p 53
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Among the 23 pathogenic mutations, 14 cause truncated connexin 26 proteins due to nonsense or frame-shift mutations, 8 are missense mutations, and one is a deletion of one amino acid. These mutations occur along the coding region. The truncation mutations account for 92.6% of the mutant alleles. Amino acids sequence homology alignment reveals that all missense mutations and unclassified variants occur at an evolutionarily conserved amino acid (Figure 2).
###end p 53
###begin p 54
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 301 308 <span type="species:ncbi:9606">patient</span>
###xml 430 437 <span type="species:ncbi:9606">patient</span>
###xml 606 611 <span type="species:ncbi:10090">mouse</span>
###xml 613 616 <span type="species:ncbi:10116">rat</span>
###xml 618 623 <span type="species:ncbi:9940">sheep</span>
###xml 625 634 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
Three missense variants, p.V63L, p.V153A, and p.V198M, are located in extracelluar domain 1, 2, and transmembrane span 4, respectively, of connexin 26 protein. All these changes have not been reported in the Connexins and Deafness mutations database at . However, p.V63L has been found in 1 Taiwanese patient [30]. These three variants likely contribute to the pathogenesis of deafness, because (a) they were detected only in the patient group and not in 394 Japanese, 864 Taiwanese, 494 Korean and 301 Chinese (in this study) hearing normal subjects, and (b) they are evolutionarily conserved in xenopus, mouse, rat, sheep, orangutan, and human (Figure. 2). These variants were found in a heterozygous state in 4 unrelated patients who carried only one mutant allele.
###end p 54
###begin p 55
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 275 282 <span type="species:ncbi:9606">patient</span>
The pathogenicity of p.V37I is controversial. In a recent multicenter study, the p.V37I mutation was found to be associated with mild to moderate hearing impairment (median 25-40 dB) [37]. Our study revealed that p.V37I with an allele frequency of 6.7% (185/2744) in the Han patient group (excluding all cases with two clearly pathogenic mutations) is significantly higher compared with that (2.8%;17/602) found in the control population (p = 0.0003, see Supplemental Table 4 and Table 5), supporting Wu's opinion to reassignment of p. V37I from an allele variant to a pathogenic mutation [38].
###end p 55
###begin p 56
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 212 219 <span type="species:ncbi:9606">patient</span>
The p.T123N is an unclassified variant. It was counted as a mutation in Japanese group but a polymorphism in a Taiwanese study [10,30]. We found a higher p.T123N allele frequency in the control group than in the patient group, suggesting that it may be neutral variant. However, its clinical implication is not clear at this time.
###end p 56
###begin p 57
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 424 428 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3</italic>
###xml 436 444 436 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 824 829 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1158 1163 1158 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 783 791 <span type="species:ncbi:9606">patients</span>
The results of this study provide a great potential benefit for the clinical application of genetic testing for deafness. Based upon our preliminary data of molecular epidemiology of hearing impairment in China [28,39-41], Li has combined allele-specific PCR and universal array (ASPUA) methodologies for the detection of mutations causing hereditary hearing loss. It was employed for multiplex detection of 11 mutations in GJB2, GJB3, SLC26A4 and mitochondrial DNA causing hereditary hearing loss [42]. Although this simple screening chip only include probes and primers for the c.35delG, c.176_c.191del16, c.235delC, c.299_c.300delAT mutations of GJB2 gene, it can detect 88.0% (650/739) of GJB2 mutations among these 2063 deaf individuals, meanwhile, up to 88.9% (384/432) of 432 patients confirmed to carry at least one GJB2 mutation by sequencing in this study will be picked up by this fast screen method. The new methods for multiple mutation detection including ASPUA with capacity to test more gene loci have been under developed in our center, the data of this study will be crucial for the mutation selection in any new technology development for GJB2 gene testing in Chinese population.
###end p 57
###begin p 58
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
In summary, this study revealed a unique GJB2 mutation spectrum in Chinese patients with nonsyndromic hearing impairment. The c.235delC mutation is the most frequent mutation in Chinese patients. Testing of four common mutations, c.235delC, c.299_c.300delAT, c.176_c.191del16, and c.35delG can detect 88.0% of the GJB2 mutant alleles. However, in some regions or sub-ethnic groups, the GJB2 mutations only account for a small fraction of the NSHI mutant alleles. In these regions, analysis of NSHI related genes is necessary. The molecular defects of more than 80% of the mutant alleles for NSHI in China remain to be identified.
###end p 58
###begin title 59
Competing interests
###end title 59
###begin p 60
The authors declare that they have no competing interests.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
PD, FY and BH carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. GW, QL, YY, XL, KY, JH, JH, YH, YW, QY, YY, HL, LL, WD, XZ, YY, JC, NH, XX, JZ, LT, RS, YL, SS, RZ, HW and YM carried out epidemiological survey.
###end p 62
###begin p 63
DK and XZ participated in the sequence alignment. SZHY and DH participated in the design of the study and performed the statistical analysis. PD, DH, XL and BW conceived of the study, and participated in its design and coordination and helped to draft the manuscript. L-JW reviewed and interpreted the results, drafted and revised the manuscript.
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
The authors would like to thank Dr. Dennis Johnson and Dr. Raye L. Alford for their valuable suggestions. This work was supported by the Chinese National Nature Science Foundation Research Grant 30728030,30872862, and Chinese Capital Medical Development Scientific Funding 2005-1032 to Dongyi Han.
###end p 65
###begin p 66
###xml 190 198 <span type="species:ncbi:9606">Children</span>
###xml 308 316 <span type="species:ncbi:9606">Children</span>
###xml 371 379 <span type="species:ncbi:9606">Children</span>
###xml 809 817 <span type="species:ncbi:9606">Children</span>
###xml 1547 1553 <span type="species:ncbi:9606">Person</span>
###xml 1624 1632 <span type="species:ncbi:9606">Children</span>
###xml 1907 1915 <span type="species:ncbi:9606">Children</span>
###xml 2024 2032 <span type="species:ncbi:9606">Children</span>
The authors also would like to thank the Fuyang School for the Deaf and Dumb (Anhui province), Beijing No.3 School for the Deaf (Beijing), Pinggu Special Education School (Beijing), Beijing Children's Hospital(Beijing), Fuzhou Special Education School (Fujian province), Lanzhou Convalescent Center for Deaf Children (Gansu province), Gansu Convalescent Ccenter for Deaf Children (Gansu province), Foshan School for the Deaf and Dumb (Guangdong province), Liuzhou School for the Bblind Deaf and Dumb (Guangxi province), Guiyang School for the Blind, Deaf and Dumb (Guizhou Province), Zhuozhou and Gaobeidian School for the Ddeaf and Dumb (Hebei province), Mudanjiang Special Education School (Heilongjiang province), Anyang Special Education School (Henan province), Wuhan Yimeng Convalescent Center for Deaf Children (Hubei province), Chifeng Special Education School (Inner Mongolia), Nantong School for the Deaf and Dumb (Jiangsu province), Haian School for the Deaf and Dumb (Jiangsu province), Haimen School for the Deaf and Dumb (Jiangsu province), Rugao School for the Deaf and Dumb (Jiangsu province), Tongzhou School for the Deaf and Dumb (Jiangsu province), Jilin Special Education School (Jilin province), Yinchuan School for the Blind, Deaf and Dumb (Ningxia Province), Xining Special Education School (Qinghai province), Changan School for the Deaf and Dumb (Shaanxi province), Affiliated Pediatric Medical Center of Shanghai Jiao Tong University (Shanghai), Yuncheng School for the Deaf and Dumb (Shanxi province), Yuncheng Disabled Person's Federation (Shanxi province), Yuncheng Convalescent Center for Deaf Children (Shanxi province), Chengdu Special Education School (Sichuan province), Urumchi School for the Deaf and Dumb (Xinjiang province), Korla School for the Deaf and Dumb (Xinjiang province), Kunming Huaxia Secondary School (Yunnan province), Kunming Convalescent Center for Deaf Children (Yunnan province), Lincang Special Education School (Yunnan province), Kunming Convalescent Center for Deaf Children (Yunnan province) and Lhasa Special Education School (Tibet municipality area) for their fundamental support and contributions to this work.
###end p 66
###begin article-title 67
Epidemiology, etiology and genetic patterns
###end article-title 67
###begin article-title 68
Universal newborn hearing screening - the Colorado story
###end article-title 68
###begin article-title 69
Newborn hearing screening: the great omission
###end article-title 69
###begin article-title 70
The Colorado newborn hearing screening project, 1992-1999: on the threshold of effective population-based universal newborn hearing screening
###end article-title 70
###begin article-title 71
###xml 39 45 <span type="species:ncbi:9606">humans</span>
Hereditary deafness and phenotyping in humans
###end article-title 71
###begin article-title 72
Connexin-26 mutations in sporadic and inherited sensorineural deafness
###end article-title 72
###begin article-title 73
Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population
###end article-title 73
###begin article-title 74
Connexin-26 mutations in sporadic non-syndromal sensorineural deafness
###end article-title 74
###begin article-title 75
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness
###end article-title 75
###begin article-title 76
GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation
###end article-title 76
###begin article-title 77
Connexin26 mutations associated with nonsyndromic hearing loss
###end article-title 77
###begin article-title 78
Molecular basis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene
###end article-title 78
###begin article-title 79
High frequency hearing loss correlated with mutations in the GJB2 gene
###end article-title 79
###begin article-title 80
Connexin 26 gene linked to a dominant deafness
###end article-title 80
###begin article-title 81
Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma
###end article-title 81
###begin article-title 82
A De Novo GJB2 (Connexin 26) Mutation, R75W, in a Chinese Pedigree With Hearing Loss and Palmoplantar Keratoderma
###end article-title 82
###begin article-title 83
Connexins, connexons, and intercellular communication
###end article-title 83
###begin article-title 84
The gap junction communication channel
###end article-title 84
###begin article-title 85
Connections with connexins: the molecular basis of direct intercellular signaling
###end article-title 85
###begin article-title 86
Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss
###end article-title 86
###begin article-title 87
A deletion involving the connexin 30 gene in nonsyndromic hearing impairment
###end article-title 87
###begin article-title 88
Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study
###end article-title 88
###begin article-title 89
Connexin 26 mutations in hereditary non-syndromic sensorineural deafness
###end article-title 89
###begin article-title 90
Prevalent connexin 26 gene (GJB2) mutations in Japanese
###end article-title 90
###begin article-title 91
Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairment
###end article-title 91
###begin article-title 92
Molecular epidemiology of DFNB1 deafness in France
###end article-title 92
###begin article-title 93
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Molecular etiology of patients with nonsyndromic hearing loss from deaf-muta schools in 18 provinces of China
###end article-title 93
###begin article-title 94
The prevalence of the 235delC GJB2 Mutation in a Chinese Deaf Population
###end article-title 94
###begin article-title 95
DNA sequence analysis of GJB2, encoding connexin 26: observations from a population of hearing impaired cases and variable carrier rates, complex genotypes, and ethnic stratification of alleles among controls
###end article-title 95
###begin article-title 96
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Mutation spectrum of the connexin 26 (GJB2) gene in Taiwanese patients with prelingual deafness
###end article-title 96
###begin article-title 97
###xml 66 74 <span type="species:ncbi:9606">children</span>
Homozygosity for the V37I Connexin 26 mutation in three unrelated children with sensorineural hearing loss
###end article-title 97
###begin article-title 98
A genotype-phenotype correlation for GJB2 (connexin 26) deafness
###end article-title 98
###begin article-title 99
GJB2 gene mutations in newborns with non-syndromic hearing impairment in Northern China
###end article-title 99
###begin article-title 100
Mutations of Cx26 gene (GJB2) for prelingual deafness in Taiwan
###end article-title 100
###begin article-title 101
GJB2 and hearing impairment: promoter defects do not explain the excess of monoallelic mutations
###end article-title 101
###begin article-title 102
Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31
###end article-title 102
###begin article-title 103
GJB2 mutations and degree of hearing loss: a multicenter study
###end article-title 103
###begin article-title 104
Effectiveness of sequencing connexin 26(GJB2) in familial or sporadic childhood deafness referred for molecular diagnostic testing
###end article-title 104
###begin article-title 105
Molecular Etiology of Hearing Impairment in Inner Mongolia: mutations in SLC26A4 gene and relevant phenotype analysis
###end article-title 105
###begin article-title 106
SLC26A4 c.919-2A>G varies among Chinese ethnic groups as a cause of hearing loss
###end article-title 106
###begin article-title 107
Extremely low penetrance of deafness associated with the mitochondrial 12S rRNA mutation in 16 Chinese families: implication for early detection and prevention of deafness
###end article-title 107
###begin article-title 108
Construction of a multiplex allele-specific PCR-based universal array (ASPUA) and its application to hearing loss screening
###end article-title 108

